bioRASI, LLC
14
0
1
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
36%
5 trials in Phase 3/4
67%
8 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Study in Subjects With Mild-to-Moderate Alzheimer's Dementia
Role: collaborator
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
Role: collaborator
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Role: collaborator
Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea
Role: collaborator
Lomecel-B Effects on Alzheimer's Disease
Role: collaborator
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
Role: collaborator
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
Role: collaborator
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Role: collaborator
Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts
Role: collaborator
Bio-equivalence Study Between SAPHRIS and Asenapine
Role: collaborator
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
Role: collaborator
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
Role: collaborator
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
Role: lead
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Role: collaborator
All 14 trials loaded